1-May-2026
Koninklijke Philips N.V. (0LNG) Receives a Buy from Barclays
TipRanks (Wed, 29-Apr 10:55 AM ET)
Market Chameleon (Thu, 23-Apr 5:12 AM ET)
Globe Newswire (Thu, 23-Apr 9:00 AM ET)
Globe Newswire (Wed, 22-Apr 9:00 AM ET)
Globe Newswire (Thu, 16-Apr 9:00 AM ET)
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member
Globe Newswire (Thu, 2-Apr 8:00 AM ET)
Globe Newswire (Thu, 26-Mar 9:10 AM ET)
Market Chameleon (Wed, 25-Mar 5:33 AM ET)
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
Globe Newswire (Wed, 25-Mar 5:00 AM ET)
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
Globe Newswire (Tue, 24-Mar 4:30 AM ET)
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Koninklijke Philips N.V. Ny Registry Shares trades on the NYSE stock market under the symbol PHG.
As of May 1, 2026, PHG stock price declined to $26.16 with 710,563 million shares trading.
PHG has a beta of 1.10, meaning it tends to be more sensitive to market movements. PHG has a correlation of 0.30 to the broad based SPY ETF.
PHG has a market cap of $24.87 billion. This is considered a Large Cap stock.
Last quarter Koninklijke Philips N.V. Ny Registry Shares reported $6 billion in Revenue and $.70 earnings per share. This beat revenue expectation by $120 million and exceeded earnings estimates by $.16.
In the last 3 years, PHG traded as high as $33.44 and as low as $17.75.
The top ETF exchange traded funds that PHG belongs to (by Net Assets): DFIV, DFIC, BINV, DFAI, AVDE.
PHG has underperformed the market in the last year with a price return of +8.4% while the SPY ETF gained +30.4%. PHG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.9% and -11.9%, respectively, while the SPY returned +4.4% and +1.5%, respectively.
PHG support price is $25.81 and resistance is $26.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHG shares will trade within this expected range on the day.